Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

UCL Policy Lab provides the latest analysis of the Chancellor's speech on removing the blockers to growth. It always used to be said that the first job of any political leader is to “own the future.” ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s the second week of the Trump administration and ...

with a lab, offices, manufacturing and warehouse facilities to employ about 200 people. But the first community park is yet to be built. The property’s master plan calls for sports fields ...

The ambitious plan to perch a major $650m swimming stadium alongside the existing Centenary Pool complex is being driven by the powerful peak aquatic sports bodies Swimming Australia, Diving ...

Australia’s leading water sports have united in a push for Brisbane to be the home to one of the greatest aquatic precincts in the world. SEE THE STUNNING DESIGNS. The ambitious plan to perch a ...

Don't miss out on the headlines from QLD News. Followed categories will be added to My News. The ambitious plan to perch a major $650m swimming stadium alongside the existing Centenary Pool ...

And they started building capacity.” Old factory sites from Princeton to Wilmington were proposed as biotech lab, manufacturing, and office centers. “Then funding dried up,” Hacherl said. “A lot of ...

A molecular diagnostics start-up founded by former IISc professor and biotech entrepreneur Vijay Chandru has recently opened a laboratory in Bengaluru for developing diagnostics for rare diseases like ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

On 13 January 2025, we had the pleasure of welcoming the Prime Minister, Sir Keir Starmer, and the Secretary of State for Science, Innovation and Technology, Peter Kyle, to the UCL East campus and the ...

US biotech Capricor Therapeutics (Nasdaq: CAPR) saw its shares leap more than 31% to $7.82 by mid-morning on positive development for its deramiocel. Capricor said that, following recent meetings with ...